Skip to main content

Table 3 Incidence of hospitalization due to chronic kidney disease in relation to complement C3 quartiles (Q1-Q4)

From: Complement C3 and incident hospitalization due to chronic kidney disease: a population-based cohort study

 

Quartile 1

Quartile 2

Quartile 3

Quartile 4

P for trend a

C3 range (g/L)

<1.3

1.31–1.49

1.50–1.71

>4.05

 

No. of subjects

1069

1195

1145

1143

Incidence (main diagnosis) b

7

16

26

45

Incidence (per 1000 person-years)

0.33

0.69

1.20

2.09

Model 1 d

Reference

2.09 (0.86, 5.07) c

3.63 (1.58, 8.36)

6.46 (2.91, 14.3)

<0.001

Model 2 e

Reference

1.86 (0.77, 4.53)

3.14 (1.36, 7.24)

5.82 (2.62, 12.9)

<0.001

Model 3 f

Reference

1.68 (0.69, 4.13)

2.71 (1.15, 6.39)

3.16 (1.36, 7.34)

0.003

Incidence (main or contributing diagnosis) g

20

38

51

77

Incidence (per 1000 person-years)

0.96

1.65

2.35

3.60

Model 1 d

Reference

1.74 (1.01, 2.98)

2.50 (1.49, 4.19)

3.89 (2.38, 6.37)

<0.001

Model 2 e

Reference

1.50 (0.87, 2.58)

2.07 (1.23, 3.48)

3.46 (2.12, 5.66)

<0.001

Model 3 f

Reference

1.39 (0.81, 2.40)

1.50 (0.88, 2.55)

1.73 (1.02, 2.92)

0.047

  1. aAnalysis by Cox proportional hazards model
  2. bIncidence of hospitalization due to chronic kidney disease (defined as 585–586 according to International Classification of Diseases (ICD) 9, and N18 and N19 according to ICD10; main diagnosis refer to cases at the first position; main or contributing diagnosis refer to cases at one of the first three positions)
  3. cAdjusted hazard ratios (95% confidence interval) (all such values)
  4. dCrude model
  5. eAdjusted for age and sex
  6. fAdjusted for age, sex, waist circumference, smoking and drinking habits, low-density lipoprotein cholesterol, diabetes, cardiovascular disease, anti-hypertensive drug medication, and baseline estimated glomerular filtration rate